Table 2 Genes reaching statistical significance (FDR ≤ 0.05) for association with MDD conditional on association with LOAD.

From: Shared genetic etiology underlying Alzheimer’s disease and major depressive disorder

SNP

Chr

Positiona

Nearest gene

Minor allele

MAF

Conditional FDR Q(MDD|LOAD)

LOAD Beta

LOAD Beta SE

LOAD P-value

MDD OR

MDD OR SE

MDD P-value

rs35591392

14

75,157,713

AREL1

T

0.53

2.82E–02

−0.047

0.014

8.83E−04

1.031

0.008

9.03E−05

rs78563874

11

85,609,073

CCDC83

T

0.24

2.76E–02

0.064

0.017

1.46E−04

0.964

0.009

9.09E−05

rs57105978

5

26,843,262

CDH9

T

0.03

2.02E–02

0.109

0.036

2.61E−03

0.930

0.019

1.20E−04

rs2071408

14

103,987,078

CKB

A

0.37

1.44E–02

0.049

0.015

1.12E−03

0.961

0.009

3.09E−06

rs7508819

20

49,205,320

FAM65C

T

0.58

1.94E–02

0.047

0.015

1.34E−03

1.031

0.008

1.79E−04

rs202675

11

49,228,613

FOLH1

C

0.28

1.79E–02

−0.054

0.016

7.43E−04

0.968

0.009

1.50E−04

rs74018295

15

57,870,174

GCOM1

T

0.09

1.90E–02

−0.077

0.026

3.13E−03

0.946

0.015

1.74E−04

rs111666866

6

32,491,925

HLA-DRB5

T

0.73

4.85E–02

0.060

0.018

8.22E−04

0.966

0.010

6.14E−04

rs4900582

14

104,058,014

KLC1

A

0.64

2.48E–02

0.052

0.016

8.84E−04

0.969

0.009

2.68E−04

rs8106047

19

18,505,741

LRRC25

A

0.16

4.31E–02

0.068

0.023

2.82E−03

0.941

0.014

1.30E−05

rs2894221

6

31,461,771

MICB

A

0.36

3.79E–02

−0.047

0.015

1.75E−03

0.968

0.008

7.42E−05

rs6664244

1

40,374,386

MYCL

T

0.36

2.47E–02

−0.057

0.015

1.32E−04

0.971

0.008

2.67E−04

rs7103992

11

48,510,777

OR4A47

A

0.65

2.84E–02

−0.045

0.015

2.26E−03

0.969

0.008

8.98E−05

rs10838830

11

48,233,932

OR4B1

A

0.35

2.42E–02

−0.044

0.015

3.06E−03

0.971

0.008

2.54E−04

rs4312096

11

48,411,653

OR4C5

C

0.65

1.93E–02

−0.045

0.015

2.66E−03

0.969

0.008

1.79E−04

rs3009872

1

66,411,400

PDE4B

T

0.43

3.87E–02

0.044

0.014

2.05E−03

1.028

0.008

4.68E−04

rs1265099

6

31,105,413

PSORS1C1

A

0.42

3.75E–02

0.048

0.015

1.07E−03

1.036

0.008

8.88E−06

rs6063534

20

49,189,168

PTPN1

T

0.51

1.80E–02

0.043

0.014

2.33E−03

1.031

0.008

1.36E−04

rs12790666

11

47,983,477

PTPRJ

A

0.52

1.79E–02

−0.045

0.014

1.71E−03

0.970

0.008

1.42E−04

rs12668707

7

4,414,425

SDK1

C

0.21

4.36E–02

−0.051

0.017

2.98E−03

1.034

0.010

5.38E−04

rs111653412

6

3,370,053

SLC22A23

T

0.02

2.38E–02

0.191

0.065

3.15E−03

0.863

0.040

2.47E−04

rs10157030

1

246,184,138

SMYD3

T

0.28

2.23E–02

0.056

0.016

5.73E−04

1.034

0.009

2.24E−04

rs6122859

20

48,610,609

SNAI1

A

0.63

3.99E–02

−0.047

0.015

2.12E−03

0.971

0.008

4.86E−04

rs7785189

7

12,257,527

TMEM106B

T

0.41

3.31E–02

−0.045

0.014

1.53E−03

1.032

0.008

7.77E−05

rs4268511

11

49,046,510

TRIM49B

A

0.64

1.81E–02

0.056

0.015

2.08E–04

1.032

0.008

1.32E−04

rs7949585

11

49,077,746

TRIM64C

T

0.60

2.00E–02

−0.051

0.015

6.11E–04

0.970

0.008

1.90E−04

rs911552

14

103,999,508

TRMT61A

A

0.37

8.94E–03

−0.051

0.015

5.98E–04

1.042

0.009

1.73E–06

  1. SNP single-nucleotide polymorphism, MAF minor allele frequency, LOAD late-onset Alzheimer’s disease, MDD major depressive disorder, FDR false discovery rate.
  2. aBuild 37, assembly hg19.